This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.

Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Ophthalmology Risk Minimisation Materials

EYLEA® (aflibercept)

Close-up-eye

Here you can find links to the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for EYLEA® (aflibercept), via the Electronics Medicines Compendium (eMC), a resource providing information about all medicines available in the UK. Please note that this information is specific to the United Kingdom and is not intended to replace the advice of a qualified doctor. For more information on EYLEA or any related support, please contact the Bayer Medical Information team on

0118 206 3116
, or email medical.information@bayer.co.uk.

 

 

EYLEA Prescriber Guide

Prescriber guide

Prescriber guide video

Prescribing information for EYLEA® (aflibercept)

.

EYLEA patient guides

All patient guides are recertified for use with original date of preparation.


Your guide to EYLEA wAMD
Your guide to EYLEA

Wet age-related macular degeneration (wAMD)

EYLEA® (aflibercept) 8 mg
Discover data and resources about EYLEA 8 mg
Ophthalmology Resources
Access useful, downloadable ophthalmology resources
EYLEA® (aflibercept) 2 mg
Discover data and resources about EYLEA 2 mg

PP-EYL-GB-2647 | December 2024